AI assistant
Sending…
ATAI Life Sciences N.V. — Director's Dealing 2021
Sep 13, 2021
32049_dirs_2021-09-13_3cee89d6-b14d-401d-9a29-bf3bc5b019df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ATAI Life Sciences N.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-09-10
Reporting Person: JOHNSON SABRINA MARTUCCI (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-10 | Stock Option | $16.46 | A | 128000 | Acquired | 2031-09-10 | Common Shares (128000) | Direct |
Footnotes
F1: The stock option shall vest with respect to a third of the underlying common shares on June 17, 2022 and in 24 substantially equal monthly installments thereafter until June 17, 2024.
More from ATAI Life Sciences N.V.
Regulatory Filings
2026
Mar 20
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 5
Capital/Financing Update
2025
Dec 5
Director's Dealing
2025
Nov 26
Interim / Quarterly Report
2025
Nov 12
Earnings Release
2025
Nov 12
Director's Dealing
2025
Nov 7